Only one of the six Olympic athletes promoting Lilly’s drugs actually took the product themselves or had a family member that did. Trulicity and Emgality TV ads include disclaimers while Verzenio commercial in memory of volleyball player April Ross’ mother does not.
Eli Lilly and Company sponsored six Olympic athletes who promoted the company’s diabetes, migraine and cancer drugs in TV commercials and on patient websites during the Tokyo Olympics. The advertisements had one striking feature: disclaimers for all but one of the athletes that they or their parents who had these diseases did not actually take the drugs.
A TV commercial for Trulicity (dulaglutide) features gymnast Laurie Hernandez and her father, who has diabetes. Superimposed text briefly...
A discussion with Karen Harris, CFO of the Alzheimer's Drug Discovery Foundation, about the foundation's investment strategy, biotech and investor sentiment at the recent BIO conference and what innovations give her hope for Alzheimer's patients.
Against a backdrop of shifting trade policies, the end of multilateral market approaches and renewed focus on supply chain resilience, medtechs are doubling down on innovation in products and processes – using AI – and keeping unmet needs and outcomes in the center of the target.
While biopharma companies experiment with genAI, agentic AI is rapidly shifting the work paradigm towards one of autonomous digital workers that can handle entire process flows.
